Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)

Cosmo Godino1,2*, MD; Guido Parodi3, MD; Shinichi Furuichi1, MD; Azeem Latib1, MD; Rossella Barbagallo4, MD; Omer Goktekin6, MD; Michela Cera1, MD; Ralf Mueller5, MD; Corrado Tamburino4, MD; Eberhard Grube5, MD; Carlo Di Mario6, MD; Bernard Reimers7, MD; Alaide Chieffo1, MD; David Antoniucci3, MD; Antonio Colombo1,2, MD; Giuseppe M. Sangiorgi8, MD